Provided by Tiger Trade Technology Pte. Ltd.

ITT Inc.

184.69
-2.2600-1.21%
Post-market: 184.690.00000.00%19:14 EDT
Volume:621.59K
Turnover:115.24M
Market Cap:15.89B
PE:30.23
High:187.78
Open:186.11
Low:184.62
Close:186.95
52wk High:209.70
52wk Low:105.64
Shares:86.04M
Float Shares:80.64M
Volume Ratio:0.54
T/O Rate:0.77%
Dividend:1.40
Dividend Rate:0.76%
EPS(TTM):6.11
EPS(LYR):6.11
ROE:14.29%
ROA:8.13%
PB:3.89
PE(LYR):30.23

Loading ...

ITT raises quarterly dividend 10% to 38.6c per share

TIPRANKS
·
Feb 05

ITT Inc. Q4 revenue rises 13% to USD 910 million

Reuters
·
Feb 05

ITT Q4 Adj. EPS $1.85 Beats $1.78 Estimate, Sales $1.054B Beat $1.008B Estimate

Benzinga
·
Feb 05

BRIEF-ITT Q4 Adjusted EPS USD 1.85 Vs. IBES Estimate USD 1.78

Reuters
·
Feb 05

ITT Q4 Revenue USD 1,054 Million

THOMSON REUTERS
·
Feb 05

ITT Inc Q1 Shr View $1.61 -- Lseg Ibes Data

THOMSON REUTERS
·
Feb 05

ITT Inc - Expects Revenue Growth of Roughly 11%, Adj EPS of $1.68 to $1.72 in Q1

THOMSON REUTERS
·
Feb 05

ITT Reports Fourth Quarter Earnings per Share (EPS) of $1.64, Adjusted EPS of $1.85; Reports Full Year EPS of $6.11, Adjusted EPS of $6.72

THOMSON REUTERS
·
Feb 05

Earning Preview: ITT Inc. Q4 revenue is expected to increase by 8.56%, and institutional views are constructive

Earnings Agent
·
Jan 29

ITT Inc. Showcases Advanced Shock and Vibration Isolation Solutions at WEST Conference

Reuters
·
Jan 28

Cardiff Oncology Announces Positive Update from its Randomized Phase 2 Trial of Onvansertib in First-line RAS-mutated mCRC

GlobeNewswire
·
Jan 27

Analysts Offer Insights on Industrial Goods Companies: Qantas Airways Limited (OtherQUBSF) and ITT (ITT)

TIPRANKS
·
Jan 27

How ITT’s High-Margin Niche Focus And Capital Allocation At ITT (ITT) Has Changed Its Investment Story

Simply Wall St.
·
Jan 26

ITT (ITT) Receives a Buy from Stifel Nicolaus

TIPRANKS
·
Jan 23

ITT Inc. Acquisition of SPX Flow Shares

Deep News
·
Jan 21

Press Release: ITT to Release 2025 Fourth Quarter and Full Year Results and 2026 Outlook on Thursday, Feb. 5

Dow Jones
·
Jan 13

Press Release: Karyopharm Announces Preliminary Unaudited 2025 Revenue and Reiterates Expectation of Delivering Potentially Transformative Phase 3 Data in 2026

Dow Jones
·
Jan 12

Will Strong Multi-Sector Demand and Earnings Beats Change ITT's (ITT) Narrative?

Simply Wall St.
·
Jan 12

ITT (ITT): Reassessing Valuation After a 25% Year-to-Date Rally and Recent Pullback

Simply Wall St.
·
Dec 26, 2025

Should ITT’s (ITT) Double-Digit Revenue Beat Prompt Investors To Reassess Its Long-Term Earnings Story?

Simply Wall St.
·
Dec 23, 2025